Pershing Square Sohn Cancer Research Alliance Prize For Young Investigators

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Pershing Square Sohn Cancer Research Alliance is taking applications for its Prize for Young Investigators in Cancer Research.

The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue research at a stage when traditional funding is lacking. Each prize winner is also given a mentor in the pharmaceutical industry and the opportunity to present his or her work to scientific and business audiences.

In May 2015, PSSCRA awarded the prize to six winners: Timothy Chan, of Memorial Sloan Kettering Cancer Center; Arvin Dar, of the Icahn School of Medicine at Mount Sinai; Evripidis Gavathiotis, of Albert Einstein College of Medicine; Moritz Kircher, of MSKCC; Christine Mayr, of MSKCC; and Sohail Tavazoie, of The Rockefeller University.

In order to apply, applicants must have between two and eight years of experience running their own laboratories and must have a Ph.D., M.D., or M.D.-Ph.D. or equivalent. The deadline to submit a letter of intent is Nov. 9.

More details on the application process, including full eligibility criteria, are available on their website.

YOU MAY BE INTERESTED IN

Growing up in inner-city Detroit, Otis Brawley had a thriving community made up of his parents, Jesuit priests, friends, and neighbors encouraging him that he could do anything he put his mind to. 
On Feb. 3, the House of Representatives passed the Senate Amendment to H.R. 7148, the Consolidated Appropriations Act, 2026, by a vote of 217 to 214. Later that day, President Donald Trump signed the bill into law, officially ending the brief partial government shutdown that began on Jan. 31. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login